Workplace safety in pharmaceutical manufacturing is no longer just a compliance checkbox. It is now central to ESG performance, business continuity, global regulatory trust, and the licence to operate in key export markets.
In a recent Express Pharma feature on India Pharma Inc’s “safety reckoning”, HRV Pharma’s MD & CEO, Hari Kiran Chereddi, explains why safety must move from plant‑level audits to boardroom KPIs. He highlights how virtual manufacturing networks, stronger EHS governance, independent audits, and digital tools can systematically raise the safety baseline across cGMP‑compliant and cGMP‑capable partner sites.
By embedding safety culture into partner selection, training, and continuous monitoring, HRV Pharma aims to protect people and communities while giving global customers confidence in a resilient, ESG‑aligned supply chain. This shift from “mere compliance” to “strong commitment” is essential for India to sustain its role as a trusted pharmacy of the world.
Full Article Link: https://www.expresspharma.in/from-compliance-to-commitment-india-pharma-incs-safety-reckoning/
